JHS Stock Overview
Manufactures, trades, and sells a range of oral and dental products for adults and kids in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
JHS Svendgaard Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹19.86 |
| 52 Week High | ₹35.70 |
| 52 Week Low | ₹15.55 |
| Beta | 0.88 |
| 1 Month Change | -14.51% |
| 3 Month Change | -25.53% |
| 1 Year Change | -40.27% |
| 3 Year Change | -28.17% |
| 5 Year Change | 48.76% |
| Change since IPO | -65.13% |
Recent News & Updates
Recent updates
JHS Svendgaard Laboratories Limited (NSE:JHS) Not Doing Enough For Some Investors As Its Shares Slump 33%
Mar 07
JHS Svendgaard Laboratories Limited's (NSE:JHS) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Jan 22A Look At The Fair Value Of JHS Svendgaard Laboratories Limited (NSE:JHS)
Aug 19There Are Reasons To Feel Uneasy About JHS Svendgaard Laboratories' (NSE:JHS) Returns On Capital
Aug 04JHS Svendgaard Laboratories (NSE:JHS) Will Want To Turn Around Its Return Trends
Apr 09Estimating The Fair Value Of JHS Svendgaard Laboratories Limited (NSE:JHS)
Dec 01Here’s What’s Happening With Returns At JHS Svendgaard Laboratories (NSE:JHS)
Jun 25
Shareholder Returns
| JHS | IN Personal Products | IN Market | |
|---|---|---|---|
| 7D | 1.4% | 1.8% | -1.8% |
| 1Y | -40.3% | -3.3% | 6.2% |
Return vs Industry: JHS underperformed the Indian Personal Products industry which returned -3.3% over the past year.
Return vs Market: JHS underperformed the Indian Market which returned 6.2% over the past year.
Price Volatility
| JHS volatility | |
|---|---|
| JHS Average Weekly Movement | 7.1% |
| Personal Products Industry Average Movement | 5.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: JHS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: JHS's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 250 | Paramvir Pabla | www.svendgaard.com |
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades, and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture tablet products under the Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Amway, Dabur, Future Group, Apollo Pharmacy, Sandika Pharma, Elder Pharma, JL Morisons, Aquawhite, 6 Ten Store, Modi Care, Infectiguard, and Odonil brands. It also provides contract manufacturing services for oral care products of other brands.
JHS Svendgaard Laboratories Limited Fundamentals Summary
| JHS fundamental statistics | |
|---|---|
| Market cap | ₹1.70b |
| Earnings (TTM) | -₹230.94m |
| Revenue (TTM) | ₹828.03m |
2.1x
P/S Ratio-7.4x
P/E RatioIs JHS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JHS income statement (TTM) | |
|---|---|
| Revenue | ₹828.03m |
| Cost of Revenue | ₹514.53m |
| Gross Profit | ₹313.50m |
| Other Expenses | ₹544.44m |
| Earnings | -₹230.94m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.70 |
| Gross Margin | 37.86% |
| Net Profit Margin | -27.89% |
| Debt/Equity Ratio | 1.6% |
How did JHS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 19:19 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
JHS Svendgaard Laboratories Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vijay Madunala | FirstCall Research |
| Shailaja CH. | FirstCall Research |